MAP Kinase Activation by Fluoxetine and Its Relation to Gene Expression in Cultured Rat Astrocytes

Cited by (176)

Items 101–176 of 176

1. Lauric acid promotes neuronal maturation mediated by astrocytes in primary cortical cultures
   Shingo Nakajima, Hiroshi Kunugi · 2020 · Heliyon
2. Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis
   Francesco Matrisciano, Morena Zusso, Isabella Panaccione, B. Turriziani, A. Caruso, Luisa Iacovelli, Lia Noviello, Giuseppina Ines Togna, Daniela Melchiorri, Patrizia Debetto et al. · 2007 · Neuropharmacology
3. Antidepressants Increase β-Arrestin2 Ubiquitinylation and Degradation by the Proteasomal Pathway in C6 Rat Glioma Cells
   Golan, Moran, Schreiber, Gabriel, Avissar, Sofia · 2010 · The Journal of Pharmacology and Experimental Therapeutics
4. Novel Antidepressant‐Like Activity of Caffeic Acid Phenethyl Ester Is Mediated by Enhanced Glucocorticoid Receptor Function in the Hippocampus
   Mi‐Sook Lee, Young Han Kim, Bo-ram Lee, Seung‐Hae Kwon, Won-Jin Moon, Kwan Su Hong, Yun Seon Song, Kyoji Morita, Dae Hyun Hahm, Insop Shim et al. · 2014 · Evidence-based Complementary and Alternative Medicine
5. Child Neuropsychology: A Journal on Normal and Abnormal Development in Childhood and Adolescence
   Else‐Marie Augusti, Hanna Karoline Torheim, Annika Maria Desiree Melinder · 2014
6. Can a Selective Serotonin Reuptake Inhibitor Act as a Glutamatergic Modulator?
   Marcos Emílio Frizzo · 2017 · Current Therapeutic Research
7. Antidepressants, β-Arrestins and GRKs: From Regulation of Signal Desensitization to Intracellular Multifunctional Adaptor Functions
   Golan, Moran, Schreiber, Gabriel, Avissar, Sofia · 2009 · Current Pharmaceutical Design
8. Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells
   Anahita Rahmani, Danial Kheradmand, Peyman Keyhanvar, Alireza Shoae‐Hassani, Amir Darbandi-Azar · 2013 · BioMed Research International
9. Deconstructing the Iboga Alkaloid Skeleton: Potentiation of FGF2-induced Glial Cell Line-Derived Neurotrophic Factor Release by a Novel Compound.
   Madalee M. Gassaway, Teresa Jacques, Andrew C. Kruegel, R. Karpowicz, Xiao-Guang Li, Shu Li, Yves Myer, D. Sames · 2016 · ACS Chemical Biology
10. The Impact of BDNF, NTRK2, NGFR, CREB1, GSK3B, AKT, MAPK1, MTOR, PTEN, ARC, and SYN1 Genetic Polymorphisms in Antidepressant Treatment Response Phenotypes
    Santos, Marlene, Lima, Luis, Carvalho, Serafim, Mota-Pereira, Jorge, Pimentel, Paulo, Maia, Dulce, Correia, Diana, Barroso, M. Fátima, Gomes, Sofia, Cruz, Agostinho et al. · 2023 · International Journal of Molecular Sciences
11. Differential BDNF Responses of Triple Versus Dual Reuptake Inhibition in Neuronal and Astrocytoma Cells as well as in Rat Hippocampus and Prefrontal Cortex
    Jos Prickaerts, Jochen De Vry, Janneke Boere, Günter Kenis, Maria S. Quinton, Sharon R. Engel, Larry Melnick, Rudy Schreiber · 2012 · Journal of Molecular Neuroscience
12. Models of Multiple System Atrophy
    Lisa Fellner, Gregor Karl Wenning, Nadia Stefanova · 2013 · Current topics in behavioral neurosciences
13. Tricyclic Antidepressant Amitriptyline Indirectly Increases the Proliferation of Adult Dentate Gyrus-Derived Neural Precursors: An Involvement of Astrocytes
    Shuken Boku, Kazue Hisaoka‐Nakashima, Shin Nakagawa, Akiko Kato, Naoto Kajitani, Takeshi Inoue, Ichiro Kusumi, Minoru Takebayashi · 2013 · PLoS ONE
14. Protective Effects of Ursolic Acid Against Cytotoxicity Induced by Corticosterone: Role of Protein Kinases
    Ana Belén Ramos-Hryb, Nicolle Platt, Andiara E. Freitas, Isabella A. Heinrich, Manuela G. López, Rodrigo Bainy Leal, Manuella Pinto Kaster, Ana Lúcia S. Rodrigues · 2019 · Neurochemical Research
15. Gender-specific role of the protein tyrosine phosphatase receptor type R gene in major depressive disorder
    Cuijuan Shi, Kerang Zhang, Qi Xu · 2011 · Journal of Affective Disorders
16. The extracellular signal-regulated kinase pathway may play an important role in mediating antidepressant-stimulated hippocampus neurogenesis in depression
    Lingxiao Wang, Daihui Peng, Bin Xie, Kaida Jiang, Yiru Fang · 2012 · Medical Hypotheses
17. Selective serotonin reuptake inhibitors facilitate ANO6 (TMEM16F) current activation and phosphatidylserine exposure
    Hyun Jong Kim, Ikhyun Jun, Jae Seok Yoon, Jinsei Jung, Yung Kyu Kim, Woo Kyung Kim, Byung Joo Kim, Jaewoo Song, Sung Joon Kim, Joo‐Hyun Nam et al. · 2015 · Pflügers Archiv - European Journal of Physiology
18. Exploring the diversity of biological processes regulated by glial cell line-derived neurotrophic factor, a pleiotropic molecule with therapeutic potential
    Cristina Porcari, Stefano Cattaneo, Lucia Crippa, Michele Simonato, Barbara Bettegazzi · 2025 · Frontiers in Physiology
19. Cure of Alzheimer’s Dementia Requires Addressing All of the Affected Brain Cell Types
    Jeffrey Fessel · 2023 · Journal of Clinical Medicine
20. Antagonistic interactions between dexamethasone and fluoxetine modulate morphodynamics and expression of cytokines in astrocytes
    Andreas Wolfram Henkel, Hanan N Alali, Anpu M Devassy, Mariam M Alawadhi, Zoran B Redzic · 2014 · Neuroscience
21. Dual effects of fluoxetine on mouse early embryonic development
    Chang-Woon Kim, Changyong Choe, Eun‐Jin Kim, Jae-Ik Lee, Sook-Young Yoon, Young‐Woo Cho, Sunkyu Han, Hyun‐Min Tak, Jaehee Han, Dawon Kang · 2012 · Toxicology and Applied Pharmacology
22. Dose-dependent modulation of apoptotic processes by fluoxetine in maturing neuronal cells: anin vitrostudy
    Ulrike Schaz, Karl J. Föhr, Stefan Liebau, Simone Fulda, Michael G. Kölch, Jörg Michael Fegert, Tobias M. Boeckers, Andrea G. Ludolph · 2010 · The World Journal of Biological Psychiatry
23. Epigenetic Effects of Childhood Adversity in the Brain and Suicide Risk
    Yogesh Dwivedi · 2012 · CRC Press eBooks
24. Contribution of NMDA, GABAA and GABAB receptors and l-arginine-NO-cGMP, MEK1/2 and CaMK-II pathways in the antidepressant-like effect of 7-fluoro-1,3-diphenylisoquinoline-1-amine in mice
    Ana Paula Pesarico, Eluza Curte Stangherlin, Suzan Gonçalves Rosa, Anderson C. Mantovani, Gilson Rogério Zeni, Cristina Wayne Nogueira · 2016 · European Journal of Pharmacology
25. The effects of antidepressants on cyclic AMP-response element-driven gene transcription in a model cell system
    W. Abdel-Razaq, Timothy Edward Bates, Dave A. Kendall · 2007 · Biochemical Pharmacology
26. Molecular programs underlying differences in the expression of mood disorders in males and females
    Mena, Fatma, Benoit, Labonté · 2019 · Brain Research
27. Synaptic Mechanisms of Activity-Dependent Remodeling in Visual Cortex during Monocular Deprivation
    Cynthia D. Rittenhouse, Ania Katarzyna Majewska · 2009 · Journal of Experimental Neuroscience
28. Serotonergic neurons in the treatment of mood disorders: The dialogue with astrocytes
    Mathieu Charvériat, Bruno Pierre Guiard · 2021 · Progress in brain research
29. Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran
    Koji Shinkai, Yumiko Toyohira, Reiji Yoshimura, Masato Tsutsui, Susume Ueno, Jun Nakamura, Nobuyuki Yanagihara · 2007 · Naunyn-Schmiedeberg s Archives of Pharmacology
30. Narrating the psychoneuroimmunomodulatory properties of serotonin 5-HT2A receptor psychedelics from a transdiagnostic perspective
    Guillaume Thuery, Christopher Sheridan, Patricia Iusan, Gurjot Brar, Kathryn Ledden, Aoife Freyne, John Richard Kelly, Andrew Harkin · 2025 · Acta Neuropsychiatrica
31. Depression and Serotonergic Changes during the Climacteric and Postmenopausal Stages: Hormonal Influences
    Rosa Isela García-Ríos, Armando Mora-Pérez, César Soria-Fregozo · 2017 · InTech eBooks
32. Formulating treatment of major psychiatric disorders: algorithm targets the dominantly affected brain cell-types
    Jeffrey Fessel · 2023 · Discover Mental Health
33. Cell-Based Systems of Depression: An Overview
    Danuta Jantas · 2016 · Springer eBooks
34. Advancement of therapies for neuroprotection in multiple sclerosis
    Albert Lo · 2008 · Expert Review of Neurotherapeutics
35. Mechanism of Paroxetine‐Induced Cell Death in Renal Tubular Cells
    Wei‐Chuan Chen, Chorng-Chih Huang, Chun‐Jen Huang, Jau‐Min Chien, Ko‐Long Lin, Yih‐Chau Lu, I-Shu Chen, Shiuh‐Inn Liu, Shu‐Shong Hsu, Hong‐Tai Chang et al. · 2008 · Basic & Clinical Pharmacology & Toxicology
36. Supplementary Pharmacotherapy for the Behavioral Abnormalities Caused by Stressors in Humans, Focused on Post-Traumatic Stress Disorder (PTSD)
    Jeffrey Fessel · 2023 · Journal of Clinical Medicine
37. Effects of fluoxetine on memory under forced treadmill exercise conditions in male rats
    Parham Reisi, Leila Jafary, Nooshin Naghsh · 2015 · Advanced Biomedical Research
38. Neuro-Protection after Traumatic Brain Injury: Novel Strategies.
    Alok Kumar Singh · 2013 · IOSR Journal of Dental and Medical Sciences
39. Role of Serotonin-2A Receptors in Pathophysiology and Treatment of Depression
    Lucia Moravčíková, Kristína Csatlósová, Barbora Ďurišová, Katarína Ondáčová, Michaela Pavlovičová, Ľubica Lacinová, Eliyahu Dremencov · 2018 · Springer eBooks
40. The Epigenetics of Depression and Suicide
    B. Labonté, G. Turecki · 2011 · Springer eBooks
41. Alkaloids
    Christophe Wiart · 2014 · Elsevier eBooks
42. Serotonin transporter immunoreactivity is modulated during development and after fluoxetine treatment in the rodent visual system
    Wandilson dos Santos Rodrigues, Priscilla Oliveira-Silva, Adriana da Cunha Faria‐Melibeu, Paula Campello‐Costa, Claudio Alberto Serfaty · 2017 · Neuroscience Letters
43. Antidepressant prescriptions in neurosurgical practice: a survey of current trends
    Ahmed B. Bayoumi, Ibrahim Efecan Efe, Özden Çağlar Öztürk, Burhan Youkus, Ayse Uzuner, Türker Kılıç, Selma Bozkurt, Zafer Orkun Toktaş · 2018 · Turkish Neurosurgery
44. Mood disorders and their treatment: alterations in the regulation of receptor‐G protein coupling
    Gabriel Schreiber, Sofia Avissar · 2005 · Drug Development Research
45. Impact of the Early-Life Environment on the Epigenome and Behavioral Development
    B. Labonté, G. Turecki · 2013 · Springer eBooks
46. Regulation of G Protein Receptor Coupling, Mood Disorders and Mechanism of Action of Antidepressants
    Moran Golan, Gabriel Schreiber, Sofia Avissar · 2009 · Springer eBooks
47. Null Effect of Antidepressants on the Astrocytes-Mediated Proliferation of Hippocampal Progenitor Cells in vitro
    Hyoung‐Gon Ko, Sung Joong Lee, Hyeon Son, Bong‐Kiun Kaang · 2007 · Molecular Pain
48. Early-Life Adversity and Epigenetic Changes
    Benoît Labonté, Adel Farah, Gustavo Turecki · 2015 · Cambridge University Press eBooks
49. Epigenomics: Epigenetic effects of childhood abuse on the human brain
    B. Labonté, G. Turecki · 2012 · Cambridge University Press eBooks
50. The epigenetics of suicide: The critical impact of environment on epigenetic regulation in suicide
    Pierre-Éric Lutz, Gustavo Turecki, Benoît Labonté · 2021 · Elsevier eBooks
51. Brain TrkB neurotrophin receptor as a target for antidepressant treatments
    Tomi Rantamäki · 2006 · Työväentutkimus Vuosikirja
52. The Role of Arrestins in the Neuroprotective Effects of Antidepressant Drugs
    Sofia Avissar, Moran Golan, Valeria Feinshtein, Siyona Kolatkar, Doron Fux, Gabriel Schreiber · 2016 · Springer eBooks
53. The Epigenetics of Suicide
    Benoît Labonté, Pierre-Éric Lutz, Gustavo Turecki · 2014 · Elsevier eBooks
54. Chronic Inflammatory Pain Alters Expression of Limbic MAPK Phosphatases
    Dakota Nerland, Allison M. Ash, Adam Garman, Jeffery B. Foltz, Gabriel Berenbeim, Benjamin Wilke, Lori Winter, Daniel Christian, Vanja Đurić · 2024 · Chronic Pain & Management
55. Chapter 15 – The Epigenetics of Suicide: The Critical Impact of the Environment on Epigenetic Regulation in Suicide
    Benoît Labonté, Pierre-Éric Lutz, Gustavo Turecki · 2014 · Academic Press eBooks
56. Neuroprotective Agents in Mood Disorders: Pathophysiological and Therapeutic Implications
    Giacomo Salvadore, Rodrigo Machado‐Vieira, Husseini K. Manji · 2010 · Springer eBooks
57. ESTUDO DO EFEITO NEUROPROTETOR DA DULOXETINA
    Daiane Fátima Engel · 2013 · Americanae (AECID Library)
58. A role for astroctye-related genes in suicide
    Carl Ernst · 2009
59. Tentative de suicide et impulsivité, aspects psychopathologiques et outils de mesures. Une évaluation du serious game « Clash-Back Tattoo or not tattoo©».
    Baptiste Le Grand · 2015 · HAL
60. Epigenetics
    Benoît Labonté, Gustavo Turecki · 2014 · Cambridge University Press eBooks
61. UNIVERSIDADE FEDERAL DE SANTA CATARINA CENTRO DE CIÊNCIAS BIOLÓGICAS PÓS-GRADUAÇÃO EM NEUROCIÊNCIAS
    Mauricio Peña Cunha · 2013
62. Fluoxetine Treatment duringIn VitroFertilization and Culture Increases Bovine Embryonic Development
    Changyong Choe, Dawon Kang · 2014 · Journal of Animal Reproduciton and Biotechnology
63. Research: Mediators and Moderators
    Stephen H. Koslow, Pedro Ruiz, Charles B. Nemeroff · 2014 · Cambridge University Press eBooks
64. Retraction note to: Chronic fluoxetine increases cytosolic phospholipase A2 activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat
    Ho‐Joo Lee, Jagadeesh Sridhara Rao, Renee N. Ertley, Lisa Chang, Stanley Isaac Rapoport, Richard Paul Bazinet · 2016 · Psychopharmacology · Retracted
65. The Role of Intracellular Signaling Pathways in the Neurobiology of the Depressive Disorder.
    Se Hyun Kim · 2011 · Saengmul jeongsin euihag/Saengmul jeongsin uihak
66. Fluoxetine Affects Glycolytic Pathway of C6 Rat Glioma Cells
    Ahmed S. Hisab · 2018 · European Scientific Journal ESJ
67. Alteraciones de las concentraciones de factor neurotrófico derivado de la línea de células gliales (GDNF) en el cerebro de pacientes con trastorno depresivo: Estudio comparativo post mortem.
    Tanja Maria Michel, Sophia Frangou, Sibylle Camara, Dorothea Thiemeyer, Julia Jecel, Thomas Tatschner, Robert Zoechling, Edna Griinblatt · 2008 · European psychiatry (Ed Española)
68. Memory in Astrocytes
    Robert M. Caudle · 2011 · Science Publishers eBooks
69. Ibogaine Modifies GDNF, BDNF and NGF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits
    Soledad Marton, Bruno González, Sebastián Rodríguez, Ernesto Miquel, Laura Martínez Palma, Mariana Pazos, José Pedro Prieto, Paola María Rodríguez, Dalibor Sameš, Gustavo A. Seoane et al. · 2018 · ChemRxiv
70. In vivo Analysis of kir4.1 Channel Expression Following Photothrombotic Stroke and Antidepressant Therapy
    Meagan Milton · 2023
71. Impact of low dose nicotine on brain-derived neurotrophic factor after global hypoxia in newborn piglets
    Karianne B. Vølstad, Maria Melheim, Marie H. Iversen, Tom Stiris, Ola Didrik Saugstad, Lars Oliver Baumbusch, Jannicke Hanne Andresen · 2025 · Journal of Perinatal Medicine
72. Neurocognitive deficits in schizophrenia and polymorphic variants of protein kinase signaling pathway genes: search for associations
    А. Н. Корнетов, Тигунцев Владимир Владимирович, Галкин Станислав Алексеевич, Михалицкая Екатерина Викторовна, Alexey A. Agarkov, A. S. Boyko, Elena G. Kornetova, Svetlana А. Ivanova · 2026 · Bulletin of Siberian Medicine
73. Progress on the neurotrophic effects of antidepressant drugs
    Pan Jing, Xi-Cheng Liu, Xiao-Peng Yin, Ye Fu, Qing Tian, Xiao-Bin Zhang · 2026 · World Journal of Psychiatry
74. Rôle des connexines 43 astrocytaires : une étude fonctionnelle dans un modèle murin de dépression basé sur le stress chronique
    Benjamin Portal · 2019 · theses.fr (ABES)
75. Role of astrocytes in the development and progression of major depressive disorder
    Pan Jing, Chao Sun, Xiao-peng YIN, Xi-Cheng Liu, Qing Tian, Xiao-Bin Zhang (673328) · 2026 · World Journal of Psychiatry
76. Mechanisms of Serotonergic Modulation of Glial Cell Functions in the Recovery Period After Spinal Cord Injury
    E. V. Nikiforova, А. Vetlugina, S. P. Konovalova, Yuriy I. Sysoev, Мусиенко Павел Евгеньевич · 2026 · Cells